Our Story
Welcome to the HIVQuant® Project!
We are thrilled to introduce our groundbreaking project, which aims to revolutionize HIV-1 research and treatment-monitoring through the development of a highly adaptable and accessible range of HIV-1 quantification kits.
Our innovative kits will be designed to make a significant impact in resource-constrained settings in particular, where cost, complexity, and infrastructure limitations often pose challenges.
We are committed to making a difference in the fight against HIV/AIDS by empowering healthcare professionals and communities with accessible and adaptable research and clinically-approved kits. Together, we can create a future where HIV research, early diagnosis and clinical care becomes efficient, cost-effective, and globally accessible.
Easy to Use
Our testing kits will boast straightforward protocols that are highly adaptable, easy to follow and can be used with crude cellular or whole blood extracts with no need for complicated nucleic acid extraction.
No Cold Chain Required
Gone are the days when strict temperature control was a prerequisite for viral load testing. Our testing kits will be a breakthrough in HIV-1 research, early detection and treatment-monitoring technology as they will not require a cold chain to function effectively.
Compatible with Any Instrument
Our kits will be meticulously designed to work on all standard qPCR instruments and isothermal assay heating blocks.
Our Mission
Our ultimate mission is to make HIV rresearch, early detection and treatment-monitoring accessible to resource
constrained settings.
In Uganda, for example, those with HIV face significant barriers to accessing early diagnosis and treatment-monitoring tests which is leading to a surge in drug resistance. District hospitals have to send blood samples to national HIV testing laboratories in Kampala, the country’s capital. Results can take over a months to get back to the district hospitals and even longer to eventually reach patients living in remote rural communities.
In fact, less than 45% of people living with HIV in Africa as a whole, have access to treatment-monitoring. So, they’re not really monitoring and detecting when they become resistant to treatment. They are spreading these drug resistant strains and thwarting our chances of attainging the 95-95-95 United Nations sustainable development goal.
The HIVQuant® project aims to revolutionize HIV-1 research and treatment monitoring through the development and dissemination of affordable, easy-to-use quantification kits that do not require a cold-chain and can be adapted to work on any suitable instrument that is available and on a variety of sample types, including crude cellular or whole-blood extact where RNA or DNA has not been purified out of the samples. These kits will make a significant impact in resource-constrained settings, where majority of the people living with HIV reside.
Driven by her dedication to improve healthcare in Africa, Dr. Kibirige is collaborating with scientists and commercialization experts globally to develop and field-test these solutions.
